Nck deficiency is associated with delayed breast carcinoma progression and reduced metastasis

David C Morris1, Julia L Popp1, Leung K Tang1

  • 1Department of Veterinary Pathobiology, Texas A&M University, College Station, Texas 77843-4467.

Insights

Noncatalytic region of tyrosine kinase (Nck) drives breast cancer growth and metastasis by regulating cell migration and invasion. Targeting Nck may offer a therapeutic strategy for aggressive cancers.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Noncatalytic region of tyrosine kinase (Nck) is known to regulate cell adhesion and migration.
  • The specific role of Nck in tumorigenesis and metastasis remained undetermined prior to this study.

Purpose of the Study:

  • To investigate the role of Nck in breast cancer progression and metastasis.
  • To elucidate the molecular mechanisms by which Nck influences tumor growth, vascularization, and cell invasion.

Main Methods:

  • Utilized a breast cancer xenograft model to assess tumor growth and lung metastasis.
  • Employed techniques such as protein silencing and forced expression of Nck variants.
  • Analyzed cell-matrix interactions, actin dynamics, invadopodia activity, and extracellular matrix proteolysis.

Main Results:

  • Nck is essential for primary tumor growth and vascularization, as well as lung metastasis in a breast cancer model.
  • Nck promotes efficient cell migration in 3D microenvironments by polarizing cell-matrix interactions.
  • Nck enhances breast carcinoma cell invasion by regulating actin dynamics at invadopodia and directing MMP14 delivery to the cell surface, linking Nck to RhoA activation and Cdc42 regulation.

Conclusions:

  • Nck is a critical driver of breast carcinoma progression and metastasis.
  • Nck acts upstream of RhoA and MMP14 to mediate breast carcinoma cell invasion.
  • These findings identify Nck as a potential therapeutic target for aggressive cancers.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
668